|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.345 MYR | -1.43% |
|
-4.17% | +15.00% |
Sunzen Biotech Berhad reported earnings results for the fourth quarter ended December 31, 2023. For the fourth quarter, the company reported sales was MYR 29.34 million. Net income was MYR 3.11 million.
Basic earnings per share from continuing operations was MYR 0.0044. Diluted earnings per share from continuing operations was MYR 0.0041.
| 1st Jan change | Capi. | |
|---|---|---|
| +15.00% | 5.27Cr | |
| -0.91% | 28TCr | |
| -1.73% | 9.65TCr | |
| -2.65% | 4.38TCr | |
| +11.05% | 4.21TCr | |
| +2.15% | 4.18TCr | |
| +9.36% | 4.03TCr | |
| -14.68% | 3.05TCr | |
| -8.06% | 2.85TCr | |
| +15.34% | 2.59TCr |
SUNZEN BIOTECH 
